Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
about
RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumoursComprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.Expression genomics and cancer biology.Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.Heterogeneity of mammary lesions represent molecular differencesDistinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.Folate, DNA methylation, and mouse models of breast tumorigenesisDisruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthRBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.Deficiency of splicing factor 1 suppresses the occurrence of testicular germ cell tumors.Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progressionDirect and indirect contribution of bone marrow-derived cells to cancer.Hypoxia and the extracellular matrix: drivers of tumour metastasisTransgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.Mammary transplantation of stromal cells and carcinoma cells in C57BL/6J miceHigh-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice.Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinomaIs breast cancer prognosis inherited?Metastasis predictive signature profiles pre-exist in normal tissues.Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.Functional genomic analysis of cancer metastasis: biologic insights and clinical implications.Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model.Genetically engineered mouse models in cancer researchGenetic background influences murine prostate gene expression: implications for cancer phenotypes.Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis.Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical modelsMouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasisIdentification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells.
P2860
Q21266554-8F3BAAE0-BF30-4411-BAA0-CCF2108EFF67Q30478981-5E090392-86F4-4003-95EA-BC16BF9D803FQ33209668-0306B693-6879-4BF0-833E-6F5CA821AA62Q33222808-ADDB85E9-66CA-4189-9AB0-3B99954354BDQ33265521-A1252C94-DC57-4957-A9C8-EE34B60E62B7Q33446416-41685CF1-372F-4B84-AE03-C49F5290889DQ33660202-B751B937-E827-45FB-8A72-1BB6EB502BB3Q33733727-9BA92D02-2D0F-4ABE-9721-7E079D91404FQ33795221-C40B1960-F79B-40C3-BC18-230EC4673E6AQ33798648-4724A940-E259-46CF-A114-A45CECAC5592Q33853533-9DF6549A-1B11-4EEA-AD0F-9A07BC20E174Q34095605-5221BD65-3B86-471A-8344-A605C74AA48EQ34134503-700BE8DA-3628-4D53-8CD2-8846C50B0605Q34472216-6F33B650-A216-48F6-99A7-BF1CCA229E21Q34636483-13BFC075-3A06-44A3-8EF4-783E25A41CEFQ34820282-996187C9-2B27-4625-B081-2A313014DF3BQ34982720-C723202E-9CD8-44DD-9669-3CD7161C0D92Q35000523-CFF92B59-3F41-4303-BF77-FE7ECB6F4DABQ35536378-8950172B-8708-47B8-B842-389D1D8E7B33Q35605840-C2E0D6D2-2251-49C4-885A-6278496F4FF1Q35679442-AD41B65A-9795-4A3A-A21C-BC76882D9548Q35691450-A4E74891-2B08-46C7-8D64-04878DB39C10Q35703904-5C0267C7-C0E9-4FE5-A21A-77C6D94614F5Q35906350-389F9355-5C19-4E2B-BDB2-3625A139661BQ36103292-1595CEFF-FEB7-49F7-96BA-23C9C0D66E50Q36110157-2DE3F470-8D9E-41BF-B48A-B235803C29B7Q36112781-74C0DFB8-781C-4CE7-8069-A599B8C8CBE1Q36150368-AB82EE30-8FA3-462A-B551-FC9756E6B7FFQ36215812-DABF18A3-4DC2-4B0B-B38D-289A3B9BE1E7Q36284318-52B1111B-4396-4CD9-9876-9E67B5A48D37Q36497718-5E8C8BFB-B22C-4842-BEDD-D08A973F13EBQ36672419-F9C1BC32-767A-4EBA-A414-95F1D98D668CQ36865586-DE466B06-05F7-4A2D-945B-F288A345EA80Q36903532-EC6BBBDA-B58B-4A0F-9D15-FA21BF874B8CQ36922699-DDE41EA4-4C15-48D6-A392-E736E49C6297Q37038608-CA38AFF6-6497-4121-8195-93848EBF4104Q37086425-B25FC696-0C6B-4136-9C8E-F3F0BB96761EQ37105376-14FC30DA-E48E-4E09-AEAA-4CB1ED580765Q37243488-2E2AA022-A022-4EEF-901E-671483177532Q37294934-449553E9-3C2A-4B58-9044-0950DEE24F0C
P2860
Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Global expression profiling id ...... correlation to human disease.
@en
Global expression profiling id ...... correlation to human disease.
@nl
type
label
Global expression profiling id ...... correlation to human disease.
@en
Global expression profiling id ...... correlation to human disease.
@nl
prefLabel
Global expression profiling id ...... correlation to human disease.
@en
Global expression profiling id ...... correlation to human disease.
@nl
P2093
P1433
P1476
Global expression profiling id ...... correlation to human disease.
@en
P2093
Edison T Liu
Gadisetti V R Chandramouli
Jeffrey E Green
Kent W Hunter
Nawal W Alkharouf
Ting Hu Qiu
P304
P356
10.1158/0008-5472.CAN-04-0242
P407
P577
2004-09-01T00:00:00Z